Lek Pharmaceuticals d.d. Remedica Ltd
PolandAll drugs from this manufacturer
-
Dasatinib Sandoz is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC: L01EA02
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in patients for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC: L01EA02
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC: L01EA02
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (from 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 100 mg ATC: L01EA02
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (over 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC: L01EA02
-
The medicine is used in adult patients for the treatment of non-small cell lung cancer.
Dosage form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC: L01EB01